Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -82.87% is in line with its 5-year average of -82.97%, around the middle of its 5-year range (-153.76%–-15.09%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.95% below its 12-month average of -80.50%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -82.87%.
RETURN ON INVESTED CAPITAL (ROIC)
-82.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-80.50%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-96.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-82.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-101.75%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-2.95%
CURRENT VS 3Y AVG
+14.51%
CURRENT VS 5Y AVG
+0.12%
CURRENT VS 10Y AVG
+18.56%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 761 covered companies
CURRENT VS SECTOR MEDIAN
-138.35%
vs the sector median at left
Entera Bio Ltd.
Market Cap
$126.92M
Return on Invested Capital (ROIC)
-82.87%
TTM Avg
-80.50%
3Y Avg
-96.94%
5Y Avg
-82.97%
Market Cap
$125.63M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-346.83%
3Y Avg
-231.85%
5Y Avg
-139.34%
Market Cap
$123.08M
Return on Invested Capital (ROIC)
-50.67%
TTM Avg
-131.41%
3Y Avg
-97.53%
5Y Avg
-74.13%
Market Cap
$122.27M
Return on Invested Capital (ROIC)
-137.40%
TTM Avg
-133.78%
3Y Avg
-372.93%
5Y Avg
-315.43%
Market Cap
$120.60M
Return on Invested Capital (ROIC)
-17.99%
TTM Avg
-23.22%
3Y Avg
-53.77%
5Y Avg
-63.92%
Market Cap
$131.78M
Return on Invested Capital (ROIC)
-314.66%
TTM Avg
-92.03%
3Y Avg
-77.08%
5Y Avg
-89.09%
Market Cap
$121.59M
Return on Invested Capital (ROIC)
-1.78%
TTM Avg
-41.34%
3Y Avg
-32.26%
5Y Avg
-28.21%
Market Cap
$121.23M
Return on Invested Capital (ROIC)
-28.87%
TTM Avg
-28.06%
3Y Avg
-25.36%
5Y Avg
-20.47%
Market Cap
$133.72M
Return on Invested Capital (ROIC)
-143.97%
TTM Avg
-52.39%
3Y Avg
-55.03%
5Y Avg
-91.26%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $126.92M | -82.87% | -80.50% | -96.94% | -82.97% |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $125.63M | N/A | -346.83% | -231.85% | -139.34% |
| Spruce Biosciences, Inc. (SPRB)vs › | $123.08M | -50.67% | -131.41% | -97.53% | -74.13% |
| TuHURA Biosciences, Inc. (HURA)vs › | $122.27M | -137.40% | -133.78% | -372.93% | -315.43% |
| Cibus, Inc. (CBUS)vs › | $120.60M | -17.99% | -23.22% | -53.77% | -63.92% |
| Pyxis Oncology, Inc. (PYXS)vs › | $131.78M | -314.66% | -92.03% | -77.08% | -89.09% |
| enGene Holdings Inc. (ENGN)vs › | $121.59M | -1.78% | -41.34% | -32.26% | -28.21% |
| Seer, Inc. (SEER)vs › | $121.23M | -28.87% | -28.06% | -25.36% | -20.47% |
| LifeMD, Inc. (LFMD)vs › | $133.72M | -143.97% | -52.39% | -55.03% | -91.26% |
| Health Catalyst, Inc. (HCAT)vs › | $133.38M | -21.42% | -8.92% | -14.86% | -16.42% |
ROIC
-82.9%
ROE
-234.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -82.87% |
| 2026-03-31 | -108.24% |
| 2025-12-31 | -83.60% |
| 2025-09-30 | -68.35% |
| 2025-06-30 | -59.41% |
| 2025-03-31 | -50.49% |
| 2024-12-31 | -116.69% |
| 2024-09-30 | -139.08% |
| 2024-06-30 | -96.65% |
| 2024-03-31 | -94.67% |
| 2023-12-31 | -83.75% |
| 2023-09-30 | -153.76% |
| 2023-06-30 | -122.61% |
| 2023-03-31 | -112.98% |
| 2022-12-31 | -110.60% |
| 2022-09-30 | -98.12% |
| 2022-06-30 | -45.94% |
| 2022-03-31 | -36.35% |
| 2021-12-31 | -25.48% |
| 2021-09-30 | -15.09% |
| 2021-06-30 | -37.59% |
| 2021-03-31 | -133.70% |
| 2020-12-31 | -137.96% |
| 2020-09-30 | -210.32% |
| 2020-06-30 | -172.73% |
| 2020-03-31 | -110.18% |
| 2019-12-31 | -93.21% |
| 2019-09-30 | -209.64% |
| 2019-06-30 | -143.33% |
| 2019-03-31 | -106.42% |
| 2018-12-31 | -94.01% |
| 2018-09-30 | 72.37% |
| 2017-12-31 | 92.71% |
| 2017-09-30 | -552.92% |
| 2017-06-30 | -293.96% |
| 2016-12-31 | -102.30% |
